Stocks

For many, the main point of investing is to generate higher returns than the overall market. But every investor is virtually certain to have both over-performing and under-performing stocks. So we wouldn't blame long term Target Healthcare REIT PLC (LON:THRL) shareholders for doubting their …

Most readers would already be aware that SIG's (LON:SHI) stock increased significantly by 33% over the past three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the current share price momentum. In this article, we decided to …

Highlights Archer has advanced its biochip development by overcoming a conventional limitation preventing many biosensing platforms from becoming broadly useful.The work builds on the significant technology development by the Company to potentially allow for the selective, complex on-chip detection of target biomolecules.Archer has developed …

/NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA./ TORONTO, March …

TORONTO, ON / ACCESSWIRE / March 9, 2023 / abrdn Asia-Pacific Income Fund VCC (TSX:FAP)(UEN:T21VC0235H) (the "Company"), a closed-end investment company trading on the Toronto Stock Exchange, announced today the results of the Annual General Meeting of Shareholders (the "Meeting"), held on March 9, …

Even if it's not a huge purchase, we think it was good to see that Duncan Gibbs, the MD, CEO & Director of Gold Road Resources Limited (ASX:GOR) recently shelled out AU$150k to buy stock, at AU$1.50 per share. Although the purchase is not …

Key Insights Kelt Exploration's estimated fair value is CA$8.51 based on 2 Stage Free Cash Flow to Equity Kelt Exploration's CA$4.98 share price signals that it might be 41% undervalued The CA$7.96 analyst price target for KEL is 6.4% less than our estimate of …